Table 1.

Genotype and allele distribution of TIM-3 and LGALS9 SNPs among ccRCC patients and controls.

			Cases		Controls
SNP	Genotype	Allele	N	%	N	%	OR	95% CI		p-Value
rs1036199
	AA		149	62.87	256	62.44	1			0.377
	AC		83	35.02	137	33.41	1.042	0.743	1.462
	CC		5	2.11	17	4.15	0.539	0.203	1.435
	AC + CC		88	37.13	154	37.56	0.983	0.707	1.367	0.913
	AA + AC		232	97.89	393	95.85	1.880	0.711	4.968	0.169
		A	381	80.38	649	79.15	1
		C	93	19.62	171	20.85	0.928	0.700	1.230	0.596
rs10057302
	CC		228	96.20	376	91.71	1			0.071
	AC		9	3.80	32	7.80	0.482	0.229	1.011
	AA		0	0.00	2	0.49	0.330	0.016	6.895
	AC + AA		9	3.80	34	8.29	0.454	0.217	0.948	0.027
	CC + AC		237	100.00	408	99.51	2.907	0.139	60.809	0.282
		C	465	98.10	784	95.61	2
		A	9	1.90	36	4.39	0.439	0.213	0.904	0.018
rs3751093
	GG		128	54.47	242	59.02	1			0.142
	AG		86	36.60	147	35.85	1.107	0.787	1.556
	AA		21	8.94	21	5.12	1.887	1.000	3.561
	AG + AA		107	45.53	168	40.98	1.204	0.872	1.663	0.261
	GG + AG		214	91.06	389	94.88	0.551	0.296	1.024	0.059
		G	342	72.77	631	76.95	1
		A	128	27.23	189	23.05	1.250	0.964	1.621	0.093
rs361497
	GG		120	51.06	225	55.42	1			0.220
	AG		93	39.57	157	38.67	1.111	0.792	1.558
	AA		22	9.36	24	5.91	1.719	0.930	3.174
	AG + AA		115	48.94	181	44.58	1.191	0.863	1.642	0.287
	GG + AG		213	90.64	382	94.09	0.608	0.335	1.103	0.103
		G	333	70.85	607	74.75	1
		A	137	29.15	205	25.25	1.219	0.946	1.571	0.128
rs4239242
	TT		91	38.56	177	43.17	1			0.307
	CT		104	44.07	178	43.41	1.136	0.801	1.610
	CC		41	17.37	55	13.41	1.451	0.902	2.332
	CT + CC		145	61.44	233	56.83	1.209	0.872	1.675	0.252
	TT + CT		195	82.63	355	86.59	0.735	0.474	1.140	0.174
		T	286	60.59	532	64.88	1
		C	186	39.41	288	35.12	1.202	0.951	1.518	0.124
rs4794976
	TT		110	46.61	210	51.22	1			0.049
	GT		92	38.98	166	40.49	1.058	0.751	1.491
	GG		34	14.41	34	8.29	1.905	1.127	3.221
	GT + GG		126	53.39	200	48.78	1.202	0.873	1.656	0.260
	TT + GT		202	85.59	376	91.71	0.538	0.326	0.888	0.015
		T	312	66.10	586	71.46	1
		G	160	33.90	234	28.54	1.285	1.007	1.638	0.044